Terbinafine Tablet
Product Images NDC 87564-010

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 87564-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amerisyn Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9d86c855 8e16 4daf Ad10 98eacdb749c1 01)

Chemical structure of terbinafine hydrochloride, illustrating its molecular components and arrangement, including aromatic rings, alkyl groups, and the hydrochloride (HCl) moiety.*

FDA Label Image

Image (9d86c855 8e16 4daf Ad10 98eacdb749c1 02)

Label for Terbinafine Tablets, USP 250 mg, oral tablet prescription drug by Amerisyn LLC. The label states the active ingredient as terbinafine hydrochloride equivalent to 250 mg terbinafine, includes storage instructions, and specifies the package contains 30 tablets. NDC 87564-010 is displayed along with manufacturer details.*

FDA Label Image

Image (9d86c855 8e16 4daf Ad10 98eacdb749c1 03)

Label for Terbinafine Tablets, USP 250 mg oral tablets by Amerisyn LLC. The label shows the NDC 87564-010-10 and indicates the product contains 100 tablets. It includes storage instructions (20° to 25°C), manufacturer information (Aavis Pharmaceuticals), barcode, and a note to dispense with a Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.